GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » Research & Development

WELL Health Technologies (TSX:WELL) Research & Development : C$0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is WELL Health Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. WELL Health Technologies's Research & Development for the three months ended in Dec. 2023 was C$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.0 Mil.

WELL Health Technologies Research & Development Historical Data

The historical data trend for WELL Health Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WELL Health Technologies Research & Development Chart

WELL Health Technologies Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WELL Health Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

WELL Health Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WELL Health Technologies  (TSX:WELL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

WELL Health Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of WELL Health Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

WELL Health Technologies (TSX:WELL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » Research & Development
Comparable Companies
TSX:SIA TSX:DNTL TSX:EXE TSX:DR TSX:CRRX TSX:AIDX TSX:NUMI TSXV:KDA TSXV:PHA TSXV:NLH HCA SZSE:300015 SAU:4013 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
WHTCF:USA W7V:Germany
Address
375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
Website
https://www.well.company
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped into three divisions; Omni-channel Patient Services - Primary includes clinical operations and allied health. Omni-channel Patient Services - Specialized comprises CRH and MyHealth under two segments. Virtual Services include EMR, billing and revenue cycle management solutions, digital apps, and cybersecurity.